Type of the Viral Infection | Type of the Nanoparticle | Description | Ref | |
---|---|---|---|---|
Influenza | TMC NPs | To successfully prevent this infection, purified HA2 and NP recombinant proteins were encapsulated in TMC NPs | [72] | |
H1N1 | PS-GAMP | PS-GAMP significantly boosted H1N1 vaccine-induced humoral and cytotoxic T-cell immune responses in mice by imitating the primary stage of illness without causing further inflammation | [73] | |
H1N1 | PEGylated ZnO-NPs | Exposure to the virus and bare ZnO-NPs at the highest non-toxic concentrations may result in a drop in viral titer | [74] | |
H3N2 | AgNPs | The inhalation route used to inject AgNPs increases survival in H3N2-infected mice | [75] | |
H1N1 | SeNPs | SeNPs inhibit lung damage in H1N1-infected mice and repress interactivity among virus and target cells | [76] | |
H1N1 | IO-NPs | These NPs prevent the virus from connecting to target cells in vitro | [77] | |
RSV | AgNPs | Curcumin-modified AgNPs have more significant antiviral activity and a more effective inhibitory impact against respiratory syncytial virus (RSV) infection | [78] |